Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Tryp Therapeutics Launches Clinical Trials to Investigate Psilocybin for Over-Eating Disorders

Tryp Therapeutics Launches Clinical Trials to Investigate Psilocybin for Over-Eating Disorders

  • Post published:February 16, 2021
  • Post category:Analysis/Editorial
Read more about the article Tryp Therapeutics Reaches Milestone on Psilocybin Drug Manufacturing Program

Tryp Therapeutics Reaches Milestone on Psilocybin Drug Manufacturing Program

  • Post published:February 16, 2021
  • Post category:Press Release
Read more about the article Tryp Therapeutics Appoints Dr. Joel Castellanos as Clinical Advisor

Tryp Therapeutics Appoints Dr. Joel Castellanos as Clinical Advisor

  • Post published:February 11, 2021
  • Post category:Press Release
Read more about the article Tryp Therapeutics Plans Phase 2a Eating Disorder Clinical Trial with Dr. Jennifer Miller

Tryp Therapeutics Plans Phase 2a Eating Disorder Clinical Trial with Dr. Jennifer Miller

  • Post published:February 8, 2021
  • Post category:Press Release
Read more about the article Tryp Therapeutics Announces Strategic Investment of $2,000,000

Tryp Therapeutics Announces Strategic Investment of $2,000,000

  • Post published:February 5, 2021
  • Post category:Press Release
Read more about the article Tryp Therapeutics Announces Appointment of Greg McKee as Executive Chairman

Tryp Therapeutics Announces Appointment of Greg McKee as Executive Chairman

  • Post published:February 3, 2021
  • Post category:Press Release
Read more about the article Tryp Therapeutics Appoints Dr. Robin Carhart-Harris to Scientific Advisory Board

Tryp Therapeutics Appoints Dr. Robin Carhart-Harris to Scientific Advisory Board

  • Post published:February 2, 2021
  • Post category:Press Release
Read more about the article Tryp Therapeutics Invited to Present at “Investing in Psychedelics” Conference

Tryp Therapeutics Invited to Present at “Investing in Psychedelics” Conference

  • Post published:January 19, 2021
  • Post category:Press Release
Read more about the article James Kuo, CEO and Co-founder of Tryp Therapeutics

James Kuo, CEO and Co-founder of Tryp Therapeutics

  • Post published:January 15, 2021
  • Post category:Interview
Read more about the article Tryp Therapeutics Strengthens Board of Directors With Appointment of Gregory M. McKee

Tryp Therapeutics Strengthens Board of Directors With Appointment of Gregory M. McKee

  • Post published:January 14, 2021
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More